Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Apr;25(3):209-13.
doi: 10.1111/j.1442-2050.2011.01249.x. Epub 2011 Sep 7.

The Prevalence of Autoimmune Disease in Patients With Esophageal Achalasia

Affiliations

The Prevalence of Autoimmune Disease in Patients With Esophageal Achalasia

J D Booy et al. Dis Esophagus. .

Abstract

Achalasia is a rare disease of the esophagus that has an unknown etiology. Genetic, infectious, and autoimmune mechanisms have each been proposed. Autoimmune diseases often occur in association with one another, either within a single individual or in a family. There have been separate case reports of patients with both achalasia and one or more autoimmune diseases, but no study has yet determined the prevalence of autoimmune diseases in the achalasia population. This paper aims to compare the prevalence of autoimmune disease in patients with esophageal achalasia to the general population. We retrospectively reviewed the charts of 193 achalasia patients who received treatment at Toronto's University Health Network between January 2000 and May 2010 to identify other autoimmune diseases and a number of control conditions. We determined the general population prevalence of autoimmune diseases from published epidemiological studies. The achalasia sample was, on average, 10-15 years older and had slightly more men than the control populations. Compared to the general population, patients with achalasia were 5.4 times more likely to have type I diabetes mellitus (95% confidence interval [CI] 1.5-19), 8.5 times as likely to have hypothyroidism (95% CI 5.0-14), 37 times as likely to have Sjögren's syndrome (95% CI 1.9-205), 43 times as likely to have systemic lupus erythematosus (95% CI 12-154), and 259 times as likely to have uveitis (95% CI 13-1438). Overall, patients with achalasia were 3.6 times more likely to suffer from any autoimmune condition (95% CI 2.5-5.3). Our findings are consistent with the impression that achalasia's etiology has an autoimmune component. Further research is needed to more conclusively define achalasia as an autoimmune disease.

Similar articles

  • Autoimmune comorbidity in achalasia patients.
    Romero-Hernández F, Furuzawa-Carballeda J, Hernández-Molina G, Alejandro-Medrano E, Núñez-Álvarez CA, Hernández-Ramírez DF, Azamar-Llamas D, Olivares-Martínez E, Breña B, Palacios A, Valdovinos MA, Coss-Adame E, Ramos-Ávalos B, Torres-Landa S, Hernández-Ávila AA, Flores-Nájera A, Torres-Villalobos G. Romero-Hernández F, et al. J Gastroenterol Hepatol. 2018 Jan;33(1):203-208. doi: 10.1111/jgh.13839. J Gastroenterol Hepatol. 2018. PMID: 28568312
  • Comprehensive epidemiological and genotype-phenotype analyses in a large European sample with idiopathic achalasia.
    Becker J, Niebisch S, Ricchiuto A, Schaich EJ, Lehmann G, Waltgenbach T, Schafft A, Hess T, Lenze F, Venerito M, Hüneburg R, Lingohr P, Matthaei H, Seewald S, Scheuermann U, Kreuser N, Veits L, Wouters MM, Gockel HR, Lang H, Vieth M, Müller M, Eckardt AJ, von Rahden BH, Knapp M, Boeckxstaens GE, Fimmers R, Nöthen MM, Schulz HG, Gockel I, Schumacher J. Becker J, et al. Eur J Gastroenterol Hepatol. 2016 Jun;28(6):689-95. doi: 10.1097/MEG.0000000000000602. Eur J Gastroenterol Hepatol. 2016. PMID: 26882171
  • Systemic autoimmune rheumatic disease prevalence in Canada: updated analyses across 7 provinces.
    Broten L, Aviña-Zubieta JA, Lacaille D, Joseph L, Hanly JG, Lix L, O'Donnell S, Barnabe C, Fortin PR, Hudson M, Jean S, Peschken C, Edworthy SM, Svenson L, Pineau CA, Clarke AE, Smith M, Bélisle P, Badley EM, Bergeron L, Bernatsky S. Broten L, et al. J Rheumatol. 2014 Apr;41(4):673-9. doi: 10.3899/jrheum.130667. Epub 2014 Mar 1. J Rheumatol. 2014. PMID: 24584928
  • Clinical expression of autoimmune diseases in older adults.
    Mishra N, Kammer GM. Mishra N, et al. Clin Geriatr Med. 1998 Aug;14(3):515-42. Clin Geriatr Med. 1998. PMID: 9664105 Review.
  • The epidemiology and significance of autoimmune diseases in health care.
    Cervera R. Cervera R. Scand J Clin Lab Invest Suppl. 2001;235:27-30. doi: 10.1080/003655101753352013. Scand J Clin Lab Invest Suppl. 2001. PMID: 11712688 Review.
See all similar articles

Cited by 16 articles

See all "Cited by" articles

MeSH terms

Feedback